Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions [PDF]
British Journal of Ophthalmology, 2007 Recent studies have suggested that macular oedema caused by central retinal vein occlusion may be treated by intravitreal triamcinolone acetonide.1–5 In these investigations, macular oedema and retinal thickening markedly decreased and visual acuity temporarily increased after the intravitreal application of triamcinolone acetonide.
Jost B, Jonas, Florian, Rensch
openaire +2 more sources
An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy [PDF]
, 2016 AIM: To evaluate the long-term efficacy and safety of dexamethasone implants in subjects affected by diabetic macular edema (DME) resistant to anti-vascular endothelial growth factor (VEGF) therapy. METHODS: Thirty-two DME patients were enrolled.
Carnovale, Anna +7 more
core +1 more source
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte +13 more
wiley +1 more source
Treating macular edema following RVO [PDF]
, 2014 Retinal vein occlusion (RVO) affects 16 million people worldwide, usually the middle-aged or older. It is caused by thrombosis, the clogging of the retinal veins, which may occur in the four branch veins – branch vein retinal occlusion (BVRO), or in the ...
Hrytsay, T.
core
Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion [PDF]
, 2016 No abstract ...
Abdolrahimzadeh, Solmaz +3 more
core +1 more source
Advanced Functional Materials, EarlyView.Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz +3 more
wiley +1 more source
ROLE OF BEVACIZUMAB FOR PREVENTION OF NEOVASCULAR GLAUCOMA IN ACUTE RETINAL VEIN OCCLUSION [PDF]
Journal of University Medical & Dental College, 2018 : There is a possibility of developing neovascular glaucoma in ischemic type of retinal vein occlusion. Purpose of the study is to determine the role of anti VEGF agent bevacizumab for prevention of neovascular glaucoma in ischemic type of retinal vein ...
Bassam Mubarik , Adeen Akram
doaj +1 more source
Association of factor V Leiden mutation with retinal vein thrombosis in a set of Iraqi patients
Iraqi Journal of Hematology, 2016 Background: Retinal vein occlusion is the most common retinal vascular disorder after diabetic retinopathy with several ocular and systemic disorders associated with retinal veins thrombosis.
Rahem Mahdy Rahem +1 more
doaj +1 more source
BMC Ophthalmology, 2023 Background To review cases of branch retinal vein occlusion (BRVO) secondary to rhegmatogenous retinal detachment (RRD) and its surgical management and presume their mechanism.
Youna Choi +7 more
doaj +1 more source
Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data [PDF]
, 2014 Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO, branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein occlusion (CRVO).
Kolář Petr
core +4 more sources